Optical probes for bioimaging of tumor-infiltrating immune cells and their applications in cancer immunotherapy

Abstract

The role of tumor-infiltrating immune cells (TIICs) in the tumor microenvironment (TME) is crucial in tumor development. The precise localization of TIICs within tumor tissues and the elucidation of their biological processes are critical for tumor diagnosis, treatment, and prognosis. Currently, optical probes with high specificity, sensitivity, and spatiotemporal resolution have emerged as powerful tools for the precise localization of TIICs and the investigation of their biological functions. In addition, the modifiability of optical biomaterials with these characteristics enables them to facilitate diverse and precise localization of TIICs and the monitoring of biological processes according to different design strategies. This review summarizes recent advancements in optical probes derived from optical biomaterials, including design strategies for TIIC-targeted optical probes, their applications in precise TIIC localization, and biological process monitoring. Furthermore, we emphasize the importance of their integration with immunotherapy, analyze the underlying factors contributing to the limited development of optical probes for regulatory T cells (Tregs), and systematically discuss the opportunities and challenges associated with their rapid advancement in tumor diagnosis and treatment.

Graphical abstract: Optical probes for bioimaging of tumor-infiltrating immune cells and their applications in cancer immunotherapy

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Review Article
Submitted
26 Feb 2026
First published
05 May 2026
This article is Open Access
Creative Commons BY-NC license

Chem. Soc. Rev., 2026, Advance Article

Optical probes for bioimaging of tumor-infiltrating immune cells and their applications in cancer immunotherapy

X. Chen, C. Hu, H. Kim, L. Zhang, Z. Zhang, H. Liu and J. Yoon, Chem. Soc. Rev., 2026, Advance Article , DOI: 10.1039/D5CS01412C

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements